Menopause and Vaginal Atrophy

Menopause brings changes in hormone levels that can cause vaginal atrophy: thinning, dryness, irritation, and decreased elasticity of vaginal tissues. These changes may lead to discomfort with intercourse, urinary symptoms, recurrent urinary or vaginal infections, or general vaginal irritation that affects quality of life.

Causes & Risk Factors:

Vaginal atrophy is driven primarily by decreased estrogen production during perimenopause and menopause. Other factors include breastfeeding, surgical menopause (oophorectomy), certain medications and smoking, which can all accelerate tissue thinning and dryness.

Treatment Options:

Anna Pelvic Health Center offers evidence-based, individualized therapies. Local estrogen treatments (creams, rings, or tablets) are highly effective for many women; non-hormonal moisturizers and lubricants provide symptomatic relief for others. For patients seeking alternative or adjunctive approaches, we discuss options such as vaginal DHEA, pelvic floor therapy, and select advanced therapies when appropriate and supported by clinical evidence.

What to Expect:

Initial consultation includes a review of symptoms and medical history to determine the safest and most effective approach. Many patients notice symptom improvement within weeks of starting therapy, with maximal benefit over a few months. Treatments are tailored to each woman’s medical profile and personal preferences to balance effectiveness and safety.

Find relief from menopausal symptoms — schedule a visit with Dr. Sara Hamade at Anna Pelvic Health Center.